These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30638075)

  • 1. Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre.
    Luigetti M; Bisogni G; Romano A; Di Paolantonio A; Barbato F; Primicerio G; Rossini PM; Servidei S; Sabatelli M
    Amyloid; 2018 Dec; 25(4):242-246. PubMed ID: 30638075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.
    Zouari HG; Ng Wing Tin S; Wahab A; Damy T; Lefaucheur JP
    Eur J Neurol; 2019 Jan; 26(1):94-e10. PubMed ID: 30102818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
    Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
    Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
    Lefaucheur JP; Zouari HG; Gorram F; Nordine T; Damy T; Planté-Bordeneuve V
    Clin Neurophysiol; 2018 Aug; 129(8):1565-1569. PubMed ID: 29883834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers.
    Lefaucheur JP; Ng Wing Tin S; Kerschen P; Damy T; Planté-Bordeneuve V
    J Neurol; 2013 Jun; 260(6):1497-503. PubMed ID: 23306657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
    Beauvais D; Labeyrie C; Cauquil C; Francou B; Eliahou L; Not A; Echaniz-Laguna A; Adam C; Slama MS; Benmalek A; Leonardi L; Rouzet F; Adams D; Algalarrondo V; Beaudonnet G
    J Neurol Neurosurg Psychiatry; 2024 May; 95(6):489-499. PubMed ID: 37875336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
    Fortanier E; Delmont E; Verschueren A; Attarian S
    Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre.
    Caponetti AG; Sguazzotti M; Accietto A; Saturi G; Ponziani A; Giovannetti A; Massa P; Ruotolo I; Sena G; Zaccaro A; Parisi V; Bonfiglioli R; Guaraldi P; Gagliardi C; Cortelli P; Galie N; Biagini E; Longhi S
    Eur J Prev Cardiol; 2024 May; 31(7):866-876. PubMed ID: 38204330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between Sudoscan and COMPASS 31: assessment of autonomic dysfunction on hATTR V30M patients.
    Conceição I; de Castro I; Castro J
    Amyloid; 2019; 26(sup1):23. PubMed ID: 31343356
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area.
    Cortese A; Vita G; Luigetti M; Russo M; Bisogni G; Sabatelli M; Manganelli F; Santoro L; Cavallaro T; Fabrizi GM; Schenone A; Grandis M; Gemelli C; Mauro A; Pradotto LG; Gentile L; Stancanelli C; Lozza A; Perlini S; Piscosquito G; Calabrese D; Mazzeo A; Obici L; Pareyson D
    J Neurol; 2016 May; 263(5):916-924. PubMed ID: 26984605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
    Masuda T; Ueda M; Suenaga G; Misumi Y; Tasaki M; Izaki A; Yanagisawa Y; Inoue Y; Motokawa H; Matsumoto S; Mizukami M; Arimura A; Deguchi T; Nishio Y; Yamashita T; Inomata Y; Obayashi K; Ando Y
    Neurology; 2017 Jun; 88(23):2192-2197. PubMed ID: 28490654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy.
    de Campos CF; Conceição I; Castro I
    Amyloid; 2019; 26(sup1):35-36. PubMed ID: 31343294
    [No Abstract]   [Full Text] [Related]  

  • 13. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations.
    Conceição I; Damy T; Romero M; Galán L; Attarian S; Luigetti M; Sadeh M; Sarafov S; Tournev I; Ueda M
    Amyloid; 2019 Mar; 26(1):3-9. PubMed ID: 30793974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis.
    De Lillo A; Pathak GA; De Angelis F; Di Girolamo M; Luigetti M; Sabatelli M; Perfetto F; Frusconi S; Manfellotto D; Fuciarelli M; Polimanti R
    Clin Epigenetics; 2020 Nov; 12(1):176. PubMed ID: 33203445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience.
    Loser V; Benkert P; Vicino A; Lim Dubois Ferriere P; Kuntzer T; Pasquier J; Maceski A; Kuhle J; Theaudin M
    J Peripher Nerv Syst; 2023 Mar; 28(1):86-97. PubMed ID: 36471582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small fibre neuropathy assessments in early stages of hATTR amyloidosis.
    González-Duarte A; Cárdenas-Soto K; Fueyo O; Bañuelos CE; Gibbons C; Freeman R
    Amyloid; 2019; 26(sup1):55-56. PubMed ID: 31343296
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy.
    Lobato L; Beirão I; Silva M; Bravo F; Silvestre F; Guimarães S; Sousa A; Noël LH; Sequeiros J
    Nephrol Dial Transplant; 2003 Mar; 18(3):532-8. PubMed ID: 12584275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience.
    Romano A; Guglielmino V; Di Paolantonio A; Bisogni G; Sabatelli M; Della Marca G; Minnella AM; Maceroni M; Bellavia S; Scala I; Sabatelli E; Rollo E; Luigetti M
    Amyloid; 2022 Dec; 29(4):270-275. PubMed ID: 36066019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misdiagnosis in late versus early onset hATTR amyloidosis patients: experience from a reference centre.
    Falcão de Campos C; Parreira S; Conceição I
    Amyloid; 2019; 26(sup1):37-38. PubMed ID: 31343293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.